Literature DB >> 3276639

Molecular and epidemiologic study of multiresistant Serratia marcescens infections in a spinal cord injury rehabilitation unit.

A E Simor1, L Ramage, L Wilcox, S B Bull, H Bialkowska-Hobrzanska.   

Abstract

Between March 1984 and February 1986, ten patients admitted to a spinal cord injury/stroke rehabilitation unit became bacteriuric with a strain of Serratia marcescens resistant to ampicillin, cephalothin, cefoxitin, ticarcillin, cotrimoxazole, gentamicin, and tobramycin. All the patients were catheterized, and in most, bacteriuria was asymptomatic. The organism was also recovered from their hospital environment (sinks, toilets, urine-collecting basins). Analysis of total plasmid content of multiresistant isolates revealed the presence of two plasmids (7 kilobase, 25.5 kilobase), not found in aminoglycoside susceptible strains of Serratia marcescens. Restriction endonuclease analysis and Southern hybridization (DNA probe: 25.5 kilobase plasmid) verified that these plasmids were identical. The 25.5 kilobase plasmid was purified, introduced by transformation into an Escherichia coli strain C recipient, and was found to mediate resistance to gentamicin and tobramycin. The emergence of multiresistant Serratia marcescens coincided with an increase in antibiotic usage on the ward. The reservoir seemed to be the urinary tracts of asymptomatic catheterized patients and their contaminated hospital environment.

Entities:  

Mesh:

Year:  1988        PMID: 3276639

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  6 in total

1.  Use of molecular typing to study the epidemiology of Serratia marcescens.

Authors:  A McGeer; D E Low; J Penner; J Ng; C Goldman; A E Simor
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 2.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit.

Authors:  G Miranda; C Kelly; F Solorzano; B Leanos; R Coria; J E Patterson
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

4.  Ribotyping provides efficient differentiation of nosocomial Serratia marcescens isolates in a pediatric hospital.

Authors:  E H Bingen; P Mariani-Kurkdjian; N Y Lambert-Zechovsky; P Desjardins; E Denamur; Y Aujard; E Vilmer; J Elion
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

5.  Three-year follow-up of an outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit.

Authors:  Baek-Nam Kim; Soon-Im Choi; Nam-Hee Ryoo
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

6.  Use of PCR to study epidemiology of Serratia marcescens isolates in nosocomial infection.

Authors:  P Y Liu; Y J Lau; B S Hu; J M Shir; M H Cheung; Z Y Shi; W S Tsai
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.